Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pike

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
Nature Ecology & Evolution|June 27, 2018
Dates for Neanderthal art and symbolic behaviour are reliableDirk L Hoffmann, Christopher D Standish, Alistair W G Pike, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2025
Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidaseNicola Colclough, Alexandra L Orton, Scott Martin, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2023
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Jordan E Eichholz, Emily S Lebow, et al.
Journal of Neurosurgery|August 30, 2024
Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastasesChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Molecular Cancer Therapeutics|September 20, 2019
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses PreclinicallyLucy C Riches, Antonio G Trinidad, Gareth Hughes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
Journal of Medicinal Chemistry|November 22, 2021
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 MethyltransferaseSharan K Bagal, Clare Gregson, Daniel H O' Donovan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Nature Ecology & Evolution|June 27, 2018
Dates for Neanderthal art and symbolic behaviour are reliableDirk L Hoffmann, Christopher D Standish, Alistair W G Pike, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2025
Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidaseNicola Colclough, Alexandra L Orton, Scott Martin, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2023
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Jordan E Eichholz, Emily S Lebow, et al.
Journal of Neurosurgery|August 30, 2024
Clinicogenomic predictors of survival and intracranial progression after stereotactic radiosurgery for colorectal cancer brain metastasesChengcheng Gui, Henry S Walch, Kirin D Mueller, et al.
Gastroenterology|August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study GroupW J Sandborn, W J Tremaine, D C Wolf, et al.
Molecular Cancer Therapeutics|September 20, 2019
Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses PreclinicallyLucy C Riches, Antonio G Trinidad, Gareth Hughes, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
Journal of Medicinal Chemistry|November 22, 2021
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 MethyltransferaseSharan K Bagal, Clare Gregson, Daniel H O' Donovan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 19, 2024
Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected MeningiomasHaley K Perlow, David R Raleigh, Tony J C Wang, et al.
Pageof 20